Current pediatric indications for cisapride: A position paper by a panel convened by the European Society for Pediatric Gastroenterology, Hepatology and Nutrition
| Data(s) |
2000
|
|---|---|
| Identificador | |
| Publicador |
Alpe Editores S.A. |
| Relação |
Vandenplas, Y., Belli, D., Badriul, H., Branski, D., Cadranel, S., Cervetto, J. L., Cleghorn, G. J., Cucchiara, S., Davidson, G. P., Dias, J. A., Dupont, C., Faure, C., Firmansyah, A., Gottrand, F., Hassall, E., Heymans, H. S. A., Quak, S. H., Jasinski, C., Kneepkens, C. M. F., Koletzko, S., Kostovski, A., Leung, Y. K., Markiewicz, M., Maherzi, A., Ramirez-Mayans, J., Milla, P., Nurko, S., Olafsdottir, E., Orsi, M., Rodrigues Silva, L., Poets, K., Polanco, I., Seo, J. K., Spolidoro, J. V., Saelzer, E., Staiano, A. M., & Szajewska, H. (2000) Current pediatric indications for cisapride: A position paper by a panel convened by the European Society for Pediatric Gastroenterology, Hepatology and Nutrition. Pediatrika, 20(10), pp. 9-19. |
| Direitos |
Copyright 2000 Alpe Editores S.A. |
| Fonte |
Faculty of Health; Institute of Health and Biomedical Innovation |
| Palavras-Chave | #cisapride #domperidone #metoclopramide #placebo #proton pump inhibitor #acetylcholine release #child #childhood disease #clinical trial #compartment model #controlled clinical trial #controlled study #cost benefit analysis #diet therapy #drug approval #drug efficacy #drug labeling #drug mechanism #drug safety #food and drug administration #gastroesophageal reflux #heart arrhythmia #human #infant #patient positioning #prematurity #QT interval #reflux esophagitis #retrospective study #review #risk factor #statistical analysis #sudden death #treatment contraindication #treatment indication #treatment planning |
| Tipo |
Journal Article |
